Molecular Assemblies

We are powering the next generation of #DNA driven products with #FES, our proprietary fully #enzymaticDNAsynthesis technology for #DNAuncompromised.

[Molecular Assemblies @molassemblies]

“Unlike traditional chemical synthesis, FES can build long and accurate sequences regardless of complexity, enabling the reliable construction of the most difficult sequences”

Read More: https://t.co/hLSFurqvEf

#FES #DNA #DNAuncompromised

[Molecular Assemblies @molassemblies]

Please join our webinar on Nov 19th featuring Konlin Shen, PhD of UCSF’s Douglas Lab & Molecular Assemblies’ Natasha Paul, PhD discussing complex genetic constructs and randomer sequences using our #FES oligos in DNAnanotechnology.

https://t.co/25jlDTDaU8

#DNA #DNAuncompromised

[Molecular Assemblies @molassemblies]

Welcome Felice Butler to the MAI team as Key Account Manager! If you are in the Pacific Northwest, Felice is ready to answer your questions on how our #enzymaticDNAsynthesis can accelerate your research and therapeutic development:

https://t.co/sdblT400Yn

#DNAuncompromised #FES

[Molecular Assemblies @molassemblies]

As we continue to increase the length of our oligos, the importance of biosecurity can't be ignored. As a member of the International Gene Synthesis Consortium, we understand our responsibility & adhere to the Harmonized Screening Protocol.

Find out more: https://t.co/P8sm5Bm1LG

[Molecular Assemblies @molassemblies]

Molecular Assemblies has partnered with Steve Bischoff, CSO and Cofounder of NovoHelix in their human pluripotent stem cell engineering, and we are excited to share the results!

Explore how precision in DNA oligos can transform your #CRISPR Research:

https://t.co/dBD6eMOF7P

[Molecular Assemblies @molassemblies]

“Molecular Assemblies became the first to enable the synthesis of oligos over 200 nucleotides, lengths that are unattainable with chemical synthesis.” Read more in the recent article from @SynBioBeta.

#FES #DNAuncompromised #SynBio

https://t.co/5XD6wpNMYi

[Molecular Assemblies @molassemblies]

Happy Manufacturing Day 🎉

As we scale up production, we are proud to showcase the talent & dedication of MAI’s production team. #MFG consistently goes above and beyond to get your long oligos reliably, fueling our mission to empower your research!

#MFGDay24 #manufacturingday

[Molecular Assemblies @molassemblies]

Secondary Structures creating a roadblock in your #synbio research? Discover why chemical DNA synthesis has struggled to make secondary structures and how Enzymatic DNA Synthesis may help you get the DNA you need.

https://t.co/CcF2qqzvpq

#DNAuncompromised #DNA #FES

[Molecular Assemblies @molassemblies]

Welcome Ronan Bates to the MAI team as our new Marketing Associate! We are excited to expand our commercial team as we spread awareness of our industry leading Fully Enzymatic Synthesis:

https://t.co/z5p5p8kDHP

#DNA #FES #DNAuncompromised

[Molecular Assemblies @molassemblies]

Struggling to get homopolymers synthesized? In our latest blog post we dissect the challenges of homopolymerization in DNA synthesis and innovative solutions to overcome them.

https://t.co/5B4ugTSpoB

[Molecular Assemblies @molassemblies]

Welcome @sesha05 to the MAI team as Key Account Manager! With over a decade of research & account management experience, he can answer your questions about our industry-leading Fully Enzymatic Synthesis: https://t.co/z5p5p8lbxn

#DNA #FES #DNAuncompromised

[Molecular Assemblies @molassemblies]

Check out this insightful discussion with our Chairman, Larry G Stambaugh on the transformative potential of synthetic biology and the exciting future we’re building at Molecular Assemblies from last years @SynBioBeta conference.

#SyntheticBiology #DNASynthesis #FES

[SynBioBeta @SynBioBeta]

What is the current state and future prospects in the field of DNA synthesis? In this session at #SynBioBeta2024, the panelists discuss the significant progress made in the field of enzymatic and chemical synthesis of DNA over the past year: https://t.co/QqjJEbF8SL #DNA #biology

[SynBioBeta @SynBioBeta]

What is the current state and future prospects in the field of DNA synthesis? In this session at #SynBioBeta2024, the panelists discuss the significant progress made in the field of enzymatic and chemical synthesis of DNA over the past year: https://t.co/QqjJEbF8SL #DNA #biology

[Molecular Assemblies @molassemblies]

We are excited to announce the extension of our involvement in the DARPA Nucleic acids On-demand Worldwide (NOW) program.

To learn more, read the release: https://t.co/IRS5MhEN7y

[Molecular Assemblies @molassemblies]

Unlock the ability to synthesize even the most complex sequences. Download our latest white paper now featuring unique complex sequences and CRISPR array construction with @DSchindler_PDR at maxGENESYS Biofoundry! https://t.co/6RUeKix8rB

#DNASynthesis #synbio #Biotech

[Molecular Assemblies @molassemblies]

AUG 1st – today’s date or a RNA start codon? It’s both! Today we celebrate World RNA Day as a nod to AUG—a codon in RNA that kickstarts protein synthesis in our cells.

Our long and complex DNA templates are perfect for RNA research.

Reach to learn more: https://t.co/kxGe9woMOt

[Molecular Assemblies @molassemblies]

Discover how our Fully Enzymatic Synthesis™ (FES™) outperforms chemical methods in length and accuracy. Perfect for CRISPR and gene assembly. Download our white paper now! https://t.co/rDLyLizCIA

#DNASynthesis #CRISPR #Biotech

[Molecular Assemblies @molassemblies]

We’re thrilled to be featured in @GENbio! The article highlights how our Fully Enzymatic Synthesis technology produces high-quality, long oligos, no matter the sequence complexity.

#DNAuncompromised #DNA

https://t.co/VnE7E62RwB

[Molecular Assemblies @molassemblies]

Today we welcome Brian LaPutka to MAI as Key Account Manager! With 15 years of product and account management experience, he's available to answer questions on how our fully #enzymaticDNAsynthesis delivers highly pure #DNA: https://t.co/sdblT400Yn

#FES #DNAuncompromised

[Molecular Assemblies @molassemblies]

#SynBio advances are moving biopharma closer to a world where treatments can be personalized and cost-effective. Thanks @davidwild77 for chatting with us for @invivonow about how #enzymaticDNAsynthesis is part of this new paradigm shift for the industry.

https://t.co/6cqtlguHVG